Search results
Showing results for
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).
Journal article
Lowe DM. et al, (2027), Lancet Microbe
Multi-objective optimisation of 3D-printed multilayer TPMS osteochondral scaffolds for enhanced mechanical and biological performance
Journal article
Xu Y. et al, (2026), Virtual and Physical Prototyping, 21
Subharmonics are not an infallible safety metric for cavitation dynamics.
Journal article
Wu Q. et al, (2026), Int J Hyperthermia, 43
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomized, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial
Journal article
Coates L., (2026), Annals of the Rheumatic Diseases
Psoriatic Arthritis and Obesity: A Review of Clinical Burden and Considerations for Comprehensive Care
Journal article
Coates L., (2026), RMD Open
AlphaEarth Satellite Embeddings for Modelling Climate Sensitive Diseases Towards Global Health Resilience
Conference paper
Nazir U. and Sara K., (2026)
Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF : post hoc analysis of SELECT-PsA 2
Journal article
Coates L., (2026), RMD Open
Immunometabolic mechanisms across psoriatic disease: Linking psoriasis to psoriatic arthritis
Journal article
Coates L. et al, (2026), Clinical Rheumatology
Hospital costs attributable to further fracture, reoperation, and death during the first year following hip fracture in England : a nationwide cohort study.
Journal article
Baji P. et al, (2026), Bone Joint J, 108-B, 952 - 960
Assessing the Importance of Variation in Diagnostic Coding Among the Three Countries in the UK Biobank.
Journal article
Clifton L. et al, (2026), Learn Health Syst, 10
Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST
Journal article
Coates LC. et al, (2026), Rheumatology
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Journal article
Coates LC. et al, (2026), RMD Open, 20, e043855 - e043855
Optimal management of pyogenic flexor tenosynovitis of the hand: a cohort study
Journal article
Hennessy M. et al, (2026), Journal of Hand and Microsurgery, 18
Metabolic control of RNA splicing by polyamines.
Journal article
Hofer SJ. et al, (2026), Trends Biochem Sci
A scoping review of guidance on sharing trial results with patients and the public finds inconsistent recommendations and limited methodological development.
Journal article
Choudhury S. et al, (2026), J Clin Epidemiol
Threat assessment shapes neutrophil cell fate upon inflammasome activation.
Journal article
Yow SJ. et al, (2026), Sci Adv, 12
Development and validation of a multimodal artificial intelligence-based model for predicting post-prostatectomy treatment outcomes from baseline biparametric prostate magnetic resonance imaging.
Journal article
Simon BD. et al, (2026), Diagn Interv Radiol
Effects of Ultrasound-Mediated Treatments on Dental Biofilm Attachment and Viability.
Journal article
De Grandi D. et al, (2026), Ultrasound Med Biol
A method for fabricating long decellularised scaffolds from skeletal muscle
Journal article
Cordelle M. et al, (2026), Tissue Engineering - Part C: Methods
BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine.
Journal article
Reinke S. et al, (2026), NPJ Vaccines